Ocugen (OCGN) Assets (2014 - 2026)
Ocugen's (OCGN) quarterly Assets came in at $56.9 million in Q1 2026, down 11.72% YoY from $64.5 million in Q1 2025, and up 30.77% on a QoQ basis from $43.5 million in Q4 2025.
Analysis
Ocugen (OCGN) Assets (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Assets data on file, last reported at $56.9 million in Q1 2026.
- Quarterly Assets fell 11.72% year-over-year to $56.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.9 million (down 11.72% YoY) and the FY2025 annual result came in at $43.5 million, down 47.22% from the prior year.
- Assets climbed to $56.9 million in Q1 2026, from $43.5 million in the prior quarter.
- In the past five years, Assets ranged from a high of $141.7 million in Q1 2022 to a low of $40.5 million in Q2 2024.
- A 5-year average of $78.5 million and a median of $64.5 million in 2023 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets soared 163.2% — and 2024, when it slumped 54.43%.
- Tracing OCGN's Assets over 5 years: stood at $108.6 million in 2022, then sank by 40.58% to $64.5 million in 2023, then gained by 27.72% to $82.4 million in 2024, then slumped by 47.22% to $43.5 million in 2025, then jumped by 30.77% to $56.9 million in 2026.
- The last three Assets figures came in at $56.9 million (Q1 2026), $43.5 million (Q4 2025), and $57.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | 124.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.21 Mn |
| Mar 31, 2026 | 56.91 Mn |
| Dec 31, 2025 | 43.52 Mn |
| Sep 30, 2025 | 57.60 Mn |
| Jun 30, 2025 | 53.59 Mn |
| Mar 31, 2025 | 64.46 Mn |
| Dec 31, 2024 | 82.44 Mn |
| Sep 30, 2024 | 61.94 Mn |
| Jun 30, 2024 | 40.54 Mn |
| Mar 31, 2024 | 51.79 Mn |
| Dec 31, 2023 | 64.55 Mn |
| Sep 30, 2023 | 74.69 Mn |
| Jun 30, 2023 | 88.98 Mn |
| Mar 31, 2023 | 96.30 Mn |
| Dec 31, 2022 | 108.63 Mn |
| Sep 30, 2022 | 116.24 Mn |
| Jun 30, 2022 | 130.09 Mn |
| Mar 31, 2022 | 141.73 Mn |
| Dec 31, 2021 | 105.76 Mn |
| Sep 30, 2021 | 116.31 Mn |